{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:10:20Z","timestamp":1782857420807,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,30]]},"DOI":"10.7759\/cureus.111839","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:30:02Z","timestamp":1782855002000},"source":"Crossref","is-referenced-by-count":0,"title":["Progressive Pelvic and Gluteal Desmoid Tumor in a 16-Year-Old Female: A Five-Year Multimodal Imaging Follow-Up"],"prefix":"10.7759","author":[{"given":"Tarek","family":"Ghamraoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Naccarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.11.013","article-title":"The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients","volume":"127","author":"Desmoid Tumor Working Group","year":"2020","unstructured":"Desmoid Tumor Working Group. The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients. Eur J Cancer. 2020, 127:96-107. 10.1016\/j.ejca.2019.11.013","journal-title":"Eur J Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx323","article-title":"An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)\/Soft Tissue and Bone Sarcoma Group (STBSG)","volume":"28","author":"Kasper B","year":"2017","unstructured":"Kasper B, Baumgarten C, Garcia J, et al.. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)\/Soft Tissue and Bone Sarcoma Group (STBSG). Ann Oncol. 2017, 28:2399-2408. 10.1093\/annonc\/mdx323","journal-title":"Ann Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2016150153","article-title":"Role of imaging in management of desmoid-type fibromatosis: a primer for radiologists","volume":"36","author":"Braschi-Amirfarzan M","year":"2016","unstructured":"Braschi-Amirfarzan M, Keraliya AR, Krajewski KM, et al.. Role of imaging in management of desmoid-type fibromatosis: a primer for radiologists. Radiographics. 2016, 36:767-782. 10.1148\/rg.2016150153","journal-title":"Radiographics"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2210140","article-title":"Nirogacestat, a \u03b3-secretase inhibitor for desmoid tumors","volume":"388","author":"Gounder M","year":"2023","unstructured":"Gounder M, Ratan R, Alcindor T, et al.. Nirogacestat, a \u03b3-secretase inhibitor for desmoid tumors. N Engl J Med. 2023, 388:898-912. 10.1056\/NEJMoa2210140","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0008","article-title":"NCCN Guidelines\u00ae Insights: kidney cancer, version 2.2024","volume":"22","author":"Motzer RJ","year":"2024","unstructured":"Motzer RJ, Jonasch E, Agarwal N, et al.. NCCN Guidelines\u00ae Insights: kidney cancer, version 2.2024. J Natl Compr Canc Netw. 2024, 22:4-16. 10.6004\/jnccn.2024.0008","journal-title":"J Natl Compr Canc Netw"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.06.017","article-title":"Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: a nationwide prospective cohort from the French Sarcoma Group","volume":"83","author":"Penel N","year":"2017","unstructured":"Penel N, Le Cesne A, Bonvalot S, et al.. Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: a nationwide prospective cohort from the French Sarcoma Group. Eur J Cancer. 2017, 83:125-131. 10.1016\/j.ejca.2017.06.017","journal-title":"Eur J Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-025-01700-3","article-title":"Management of desmoid tumors","volume":"27","author":"Grilley-Olson JE","year":"2025","unstructured":"Grilley-Olson JE, Sotolongo G, Jeck WR, Kim CY, Larrier N, Blazer Iii DG, Riedel RF. Management of desmoid tumors. Curr Oncol Rep. 2025, 27:1209-1220. 10.1007\/s11912-025-01700-3","journal-title":"Curr Oncol Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30276-1","article-title":"Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study","volume":"20","author":"Toulmonde M","year":"2019","unstructured":"Toulmonde M, Pulido M, Ray-Coquard I, et al.. Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study. Lancet Oncol. 2019, 20:1263-1272. 10.1016\/S1470-2045(19)30276-1","journal-title":"Lancet Oncol"},{"key":"ref9","unstructured":"A safety, pharmacokinetic and efficacy study of a y-secretase inhibitor, nirogacestat (PF-03084014), in children and adolescents with progressive, surgically unresectable desmoid tumors. (2019). Accessed. November 14, 2025: https:\/\/clinicaltrials.gov\/study\/NCT04195399."},{"key":"ref10","article-title":"Desmoid tumor of the rectus abdominis with urinary bladder involvement: a case report and review of literature","volume":"1","author":"Alfentoukh M","year":"2023","unstructured":"Alfentoukh M, Salih A, Hassan ME, Alghamdi O, Alkhawaja KA, Ibrahim MA, Sabir EI. Desmoid tumor of the rectus abdominis with urinary bladder involvement: a case report and review of literature. Gulf J Oncolog. 2023, 1:100-106.","journal-title":"Gulf J Oncolog"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-14-69","article-title":"Desmoid tumor of posterior cruciate ligament of the knee: a case report","volume":"14","author":"Ling W","year":"2013","unstructured":"Ling W, Kedong S, Hong W, Weiguo Z, Decheng L. Desmoid tumor of posterior cruciate ligament of the knee: a case report. BMC Musculoskelet Disord. 2013, 14:69. 10.1186\/1471-2474-14-69","journal-title":"BMC Musculoskelet Disord"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.CC.18.00211","article-title":"Intra-articular osteoid osteoma of the distal femur treated with osteochondral grafting: a report of 2 cases","volume":"9","author":"Monroe EJ","year":"2019","unstructured":"Monroe EJ, Chambers CC, Davoodian A, Cho SJ, Motamedi D, Allen CR. Intra-articular osteoid osteoma of the distal femur treated with osteochondral grafting: a report of 2 cases. JBJS Case Connect. 2019, 9:e0211. 10.2106\/JBJS.CC.18.00211","journal-title":"JBJS Case Connect"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/SAP.0b013e31827f4dea","article-title":"Desmoid tumor of the hand: a case report","volume":"73","author":"Maher J","year":"2014","unstructured":"Maher J, Smith DA, Parker WL. Desmoid tumor of the hand: a case report. Ann Plast Surg. 2014, 73:390-392. 10.1097\/SAP.0b013e31827f4dea","journal-title":"Ann Plast Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjorl.2019.12.006","article-title":"The styloid process and the formation of sigmoid sinus diverticulum: is there a link?","volume":"87","author":"Lou ZC","year":"2021","unstructured":"Lou ZC. The styloid process and the formation of sigmoid sinus diverticulum: is there a link?. Braz J Otorhinolaryngol. 2021, 87:545-549. 10.1016\/j.bjorl.2019.12.006","journal-title":"Braz J Otorhinolaryngol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.794512","article-title":"Case report: tyrosine kinase inhibitors induced lymphadenopathy in desmoid tumor patients","volume":"13","author":"Papadopoulos S","year":"2022","unstructured":"Papadopoulos S, Koulouris P, Royer-Chardon C, et al.. Case report: tyrosine kinase inhibitors induced lymphadenopathy in desmoid tumor patients. Front Endocrinol (Lausanne). 2022, 13:794512. 10.3389\/fendo.2022.794512","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-022-00733-9","article-title":"Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke","volume":"27","author":"Lin KB","year":"2022","unstructured":"Lin KB, Fan FH, Cai MQ, et al.. Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke. Eur J Med Res. 2022, 27:106. 10.1186\/s40001-022-00733-9","journal-title":"Eur J Med Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/496235-progressive-pelvic-and-gluteal-desmoid-tumor-in-a-16-year-old-female-a-five-year-multimodal-imaging-follow-up","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:30:10Z","timestamp":1782855010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/496235-progressive-pelvic-and-gluteal-desmoid-tumor-in-a-16-year-old-female-a-five-year-multimodal-imaging-follow-up"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.111839","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,30]]}}}